Hiroaki Kobayashi

1.7k total citations
28 papers, 1.4k citations indexed

About

Hiroaki Kobayashi is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Hiroaki Kobayashi has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Reproductive Medicine. Recurrent topics in Hiroaki Kobayashi's work include Angiogenesis and VEGF in Cancer (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Melanoma and MAPK Pathways (3 papers). Hiroaki Kobayashi is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Melanoma and MAPK Pathways (3 papers). Hiroaki Kobayashi collaborates with scholars based in Japan, Canada and United States. Hiroaki Kobayashi's co-authors include Robert S. Kerbel, Charles H. Graham, Toshiharu Kamura, Satoshi Amada, Toshio Hirakawa, Beverly A. Teicher, Si Ming Man, Shinji Ogawa, Hitoo Nakano and Hitoo Nakano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer.

In The Last Decade

Hiroaki Kobayashi

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Kobayashi Japan 18 741 379 289 229 157 28 1.4k
David A. Sampson United States 12 371 0.5× 254 0.7× 209 0.7× 147 0.6× 187 1.2× 23 1.1k
Amy E. Birsner United States 21 644 0.9× 176 0.5× 197 0.7× 149 0.7× 187 1.2× 34 1.2k
Karen D. Cowden Dahl United States 15 678 0.9× 277 0.7× 102 0.4× 124 0.5× 432 2.8× 26 1.1k
Mary Ellen Urick United States 16 672 0.9× 227 0.6× 339 1.2× 330 1.4× 352 2.2× 22 1.3k
Gary K. Yiu United States 13 990 1.3× 379 1.0× 282 1.0× 47 0.2× 245 1.6× 15 1.5k
Yuzhen Feng China 14 462 0.6× 230 0.6× 97 0.3× 126 0.6× 145 0.9× 30 827
Liat Drucker Israel 20 537 0.7× 320 0.8× 75 0.3× 94 0.4× 203 1.3× 71 1.1k
Mark G. Cadungog United States 12 540 0.7× 629 1.7× 243 0.8× 73 0.3× 148 0.9× 17 1.3k
Takeshi Motohara Japan 14 634 0.9× 427 1.1× 186 0.6× 66 0.3× 333 2.1× 29 1.1k
Cecilia S. Leung United States 11 1.2k 1.6× 450 1.2× 242 0.8× 35 0.2× 824 5.2× 17 1.7k

Countries citing papers authored by Hiroaki Kobayashi

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kobayashi more than expected).

Fields of papers citing papers by Hiroaki Kobayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kobayashi. The network helps show where Hiroaki Kobayashi may publish in the future.

Co-authorship network of co-authors of Hiroaki Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kobayashi. A scholar is included among the top collaborators of Hiroaki Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kobayashi. Hiroaki Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Hiroaki, et al.. (2023). CsgI (YccT) Is a Novel Inhibitor of Curli Fimbriae Formation in Escherichia coli Preventing CsgA Polymerization and Curli Gene Expression. International Journal of Molecular Sciences. 24(5). 4357–4357. 8 indexed citations
2.
Kunoh, Tatsuki, Weixiang Wang, Hiroaki Kobayashi, et al.. (2015). Human Dynactin-Associated Protein Transforms NIH3T3 Cells to Generate Highly Vascularized Tumors with Weak Cell-Cell Interaction. PLoS ONE. 10(8). e0135836–e0135836. 2 indexed citations
3.
Kobayashi, Hiroaki, et al.. (2013). CW/pulsed NIR irradiation of gold nanorods: Effect on transdermal protein delivery mediated by photothermal ablation. Journal of Controlled Release. 171(2). 178–183. 35 indexed citations
4.
Takao, Tomoka, Ryosuke Tsunematsu, Seiichi Morokuma, et al.. (2012). Inhibition of AHR transcription by NF1C is affected by a single-nucleotide polymorphism, and is involved in suppression of human uterine endometrial cancer. Oncogene. 32(41). 4950–4959. 27 indexed citations
5.
Ohishi, Yoshihiro, Yoshinao Oda, Shuichi Kurihara, et al.. (2011). Nuclear localization of E‐cadherin but not beta‐catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma. Histopathology. 58(3). 423–432. 24 indexed citations
6.
Kobayashi, Hiroaki, Masahiro Yamada, Mitsutaka Taniguchi, et al.. (2008). Differential Positioning of C4 Mesophyll and Bundle Sheath Chloroplasts: Recovery of Chloroplast Positioning Requires the Actomyosin System. Plant and Cell Physiology. 50(1). 129–140. 19 indexed citations
7.
Yagi, Hiroshi, Shingo Miyamoto, Yoïchi Tanaka, et al.. (2005). Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer. British Journal of Cancer. 92(9). 1737–1745. 54 indexed citations
8.
Nakano, Hitoo, et al.. (2004). In vivo establishment and characterization of a paclitaxel-resistant human ovarian cancer cell line showing enhanced growth properties and drug-resistance only in vivo. Journal of Cancer Research and Clinical Oncology. 130(3). 178–186. 13 indexed citations
9.
10.
Ogawa, Shinji, Tsunehisa Kaku, Satoshi Amada, et al.. (2000). Ovarian Endometriosis Associated with Ovarian Carcinoma: A Clinicopathological and Immunohistochemical Study. Gynecologic Oncology. 77(2). 298–304. 212 indexed citations
11.
Kamura, Toshiharu, Hideaki Yahata, Satoshi Amada, et al.. (1999). Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?. Cancer. 85(11). 2450–2454. 103 indexed citations
12.
Kaku, Tsunehisa, Toshio Hirakawa, Toshiharu Kamura, et al.. (1998). Angiogenesis in adenocarcinoma of the uterine cervix. Cancer. 83(7). 1384–1390. 27 indexed citations
13.
14.
Sakurai, Akihiro, Satoru Suzuki, Miyuki Katai, et al.. (1995). Transcriptional regulation of human thyroid hormone receptor β1 gene expression: effect of human retinoid X receptor and identification of a transcriptional silencer region. Molecular and Cellular Endocrinology. 110(1-2). 103–112. 7 indexed citations
15.
Katakura, Masafumi, et al.. (1995). Ketoacidosis-Onset Noninsulin Dependent Diabetes in Japanese Subjects. The American Journal of the Medical Sciences. 310(5). 198–201. 38 indexed citations
16.
Kerbel, Robert S., Hiroaki Kobayashi, & Charles H. Graham. (1994). Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes?. Journal of Cellular Biochemistry. 56(1). 37–47. 89 indexed citations
17.
Lü, Chao, Janusz Rak, Hiroaki Kobayashi, & Robert S. Kerbel. (1993). Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.. PubMed. 53(12). 2708–11. 40 indexed citations
18.
Hashizume, Kiyoshi, Kazuo Ichikawa, Teiji Takeda, et al.. (1993). Induction of Cytosolic Triiodo-L-Thyronine (T3) Binding Protein (CTBP) by T3 in Primary Cultured Rat Hepatocytes.. Endocrine Journal. 40(4). 399–404. 7 indexed citations
19.
Kobayashi, Hiroaki, et al.. (1993). Acquired multicellular-mediated resistance to alkylating agents in cancer.. Proceedings of the National Academy of Sciences. 90(8). 3294–3298. 228 indexed citations
20.
Hasuda, Keitaro, Hiroaki Kobayashi, Toshiro Kuroiwa, et al.. (1989). Efficacy of Two‐route Chemotherapy Using Intraperitoneal Neocarzinostatin and Its Antidote, Intravenous Tiopronin, for Peritoneally Disseminated Tumors in Mice. Japanese Journal of Cancer Research. 80(3). 283–289. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Sampson Breakdown of academic impact, for papers by Amy E. Birsner Breakdown of academic impact, for papers by Karen D. Cowden Dahl Breakdown of academic impact, for papers by Mary Ellen Urick Breakdown of academic impact, for papers by Gary K. Yiu Breakdown of academic impact, for papers by Yuzhen Feng Breakdown of academic impact, for papers by Liat Drucker Breakdown of academic impact, for papers by Mark G. Cadungog Breakdown of academic impact, for papers by Takeshi Motohara Breakdown of academic impact, for papers by Cecilia S. Leung
Rankless by CCL
2026